Home › Type 1 Diabetes › Indiana › Indianapolis

Pag-aaral pangklinika para sa Type 1 Diabetes sa Indianapolis, IN

14 pag-aaral para sa Type 1 Diabetes ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Indianapolis (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Finding Immune Nascent Type 1 Diabetes

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Indiana University School of Medicine, Indianapolis

Edad 1 hanggang 99 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07663136

App-Based Certified Diabetes Education Therapy (AB-CDE)

Nagre-recruit

Indiana University, Indianapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07282639

Type 1 Diabetes Extension Study

Nagre-recruitObservasyonal na pag-aaral

Indiana University Riley Hospital for Children, Indianapolis

Edad 8 hanggang 35 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT02734277

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Nagre-recruitPhase 1/2

Riley Hospital for Children- Indiana University, Indianapolis

Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06783309

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Nagre-recruitPhase 2

Indiana University-Riley Hospital for Children, Indianapolis

Edad 8 hanggang 45 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07142252

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Nagre-recruitPhase 1/2

Indiana University, Indianapolis

Edad 9 hanggang 20 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07061574

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

Nagre-recruitPhase 2

IUH - Riley Hospital for Children - Riley Outpatient Center - Pediatric Diabetes & Endocrinology, Indianapolis

Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07187531

The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action

Nagre-recruitPhase 2

Indiana University School of Medicine, Indianapolis

Edad 11 hanggang 18 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT05414409

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Nagre-recruitPhase 2

Indiana University, Indianapolis

Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07224321

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

Nagre-recruit

Indiana University, Indianapolis

Edad 14 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07579702

Denosumab for Type 1 Diabetes

Nagre-recruitPhase 1/2

Indiana University, Indianapolis

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT06524960

Registry for Stage 2 Type 1 Diabetes

Nagre-recruitObservasyonal na pag-aaral

Indiana University Health Riley Hospital for Children- Site Number : 8400004, Indianapolis

Lahat ng edad · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06481904

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Nagre-recruit

Indiana University Health, Univeristy hospital, Indianapolis

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 18, 2026 · NCT07287943

TrialNet Pathway to Prevention of T1D

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Riley Hospital for Children, Indiana University, Indianapolis

Edad 2 hanggang 45 · Lahat ng kasarian · Na-update Hul 1, 2025 · NCT00097292

Pag-aaral para sa Type 1 Diabetes sa ibang lungsod

Iba pang pag-aaral sa Indianapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.